Yi‐Nan Liu

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

Yi‐Nan Liu, Meng‐Feng Tsai, Shang‐Gin Wu et al. · International Journal of Cancer · 2019 · 62 citations · Full text

Medicine, Oncology, Pharmacology +16

Modeling vanishing white matter disease with patient‐derived induced pluripotent stem cells reveals astrocytic dysfunction

Ling Zhou, Peng Li, Na Chen et al. · CNS Neuroscience & Therapeutics · 2019 · 44 citations · Full text

Life Sciences, Cell Biology, Neuroscience +17

A Minority Subpopulation of <scp>CD</scp>133⁺/<scp>EGFR</scp>v<scp>III</scp>⁺/<scp>EGFR</scp>⁻ Cells Acquires Stemness and Contributes to Gefitinib Resistance

Xujie Liu, Wentao Wu, Weihua Wu et al. · CNS Neuroscience & Therapeutics · 2013 · 23 citations · Full text

Medicine, Cell Biology, Oncology +16

Isolation and characterization of epithelial progenitor cells from human fetal liver

Yi‐Nan Liu, Jun Zhang, Qihua He et al. · Hepatology Research · 2007 · 18 citations

Life Sciences, Cell Biology, Pathology +14

Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion

Shang‐Gin Wu, Yi‐Nan Liu, Chong‐Jen Yu et al. · Genes Chromosomes and Cancer · 2018 · 17 citations

Medicine, Genetics, Oncology +17